LOGO
LOGO

Corporate News

AngioDynamics Stock Rises 13% As Q3 Net Loss Narrows

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

AngioDynamics, Inc. (ANGO) is trading at $10.92, up 13.01 percent or $1.26 during Wednesday's trading, following the release of its latest third quarter financial results, which revealed net loss of $4.41 million, an improvement from a $5.49 million loss in the comparable period.

The stock opened at $10.93 and has traded between $10.21 and $11.72 so far today, compared to a previous close of $9.66. Volume has reached 1.3 million shares, nearly double its average of 695,868. The stock's 52-week range is between $5.47 and $13.50.

The company reported net sales of $72 million for the third quarter, in line with the prior year's $72 million, but slightly below the $75 million reported in a previous quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor.
Global Economics Weekly Update - Jun 08-12, 2026

June 12, 2026 17:14 ET
Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.

RELATED NEWS